Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
AXL expression
i
Other names:
AXL Receptor Tyrosine Kinase, Tyrosine Protein Kinase Receptor UFO, AXL Oncogene, AXL Transforming Sequence Gene, Tyro7
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
558
Related biomarkers:
Expression
Mutation
CNA
Others
‹
AXL elevation (2)
AXL expression + EGFR mutation (2)
AXL-L (2)
AXL elevation + GAS6 elevation (1)
AXL overexpression + EGFR mutation (1)
AXL overexpression + KRAS G12C (1)
AXL underexpression + EGFR mutation (1)
HER-2 amplification + AXL expression (1)
KRAS mutation + STK11 mutation + AXL expression (1)
AXL elevation (2)
AXL expression + EGFR mutation (2)
AXL-L (2)
AXL elevation + GAS6 elevation (1)
AXL overexpression + EGFR mutation (1)
AXL overexpression + KRAS G12C (1)
AXL underexpression + EGFR mutation (1)
HER-2 amplification + AXL expression (1)
KRAS mutation + STK11 mutation + AXL expression (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
AXL expression
Non Small Cell Lung Cancer
AXL expression
Non Small Cell Lung Cancer
pembrolizumab + BGB324
Sensitive: C2 – Inclusion Criteria
pembrolizumab + BGB324
Sensitive
:
C2
pembrolizumab + BGB324
Sensitive: C2 – Inclusion Criteria
pembrolizumab + BGB324
Sensitive
:
C2
AXL expression
Colorectal Cancer
AXL expression
Colorectal Cancer
cetuximab
Resistant: C3 – Early Trials
cetuximab
Resistant
:
C3
cetuximab
Resistant: C3 – Early Trials
cetuximab
Resistant
:
C3
AXL expression
Melanoma
AXL expression
Melanoma
ipilimumab
Resistant: C3 – Early Trials
ipilimumab
Resistant
:
C3
ipilimumab
Resistant: C3 – Early Trials
ipilimumab
Resistant
:
C3
AXL expression
Renal Cell Carcinoma
AXL expression
Renal Cell Carcinoma
nivolumab
Resistant: C3 – Early Trials
nivolumab
Resistant
:
C3
nivolumab
Resistant: C3 – Early Trials
nivolumab
Resistant
:
C3
AXL expression
Non Small Cell Lung Cancer
AXL expression
Non Small Cell Lung Cancer
gefitinib
Resistant: C3 – Early Trials
gefitinib
Resistant
:
C3
gefitinib
Resistant: C3 – Early Trials
gefitinib
Resistant
:
C3
AXL expression
Breast Cancer
AXL expression
Breast Cancer
ADCT-601
Sensitive: C3 – Early Trials
ADCT-601
Sensitive
:
C3
ADCT-601
Sensitive: C3 – Early Trials
ADCT-601
Sensitive
:
C3
AXL expression
Renal Cell Carcinoma
AXL expression
Renal Cell Carcinoma
sunitinib
Sensitive: D – Preclinical
sunitinib
Sensitive
:
D
sunitinib
Sensitive: D – Preclinical
sunitinib
Sensitive
:
D
AXL expression
Prostate Cancer
AXL expression
Prostate Cancer
BA3011
Sensitive: D – Preclinical
BA3011
Sensitive
:
D
BA3011
Sensitive: D – Preclinical
BA3011
Sensitive
:
D
AXL expression
Pancreatic Cancer
AXL expression
Pancreatic Cancer
BA3011
Sensitive: D – Preclinical
BA3011
Sensitive
:
D
BA3011
Sensitive: D – Preclinical
BA3011
Sensitive
:
D
AXL expression
Lung Cancer
AXL expression
Lung Cancer
BA3011
Sensitive: D – Preclinical
BA3011
Sensitive
:
D
BA3011
Sensitive: D – Preclinical
BA3011
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login